<SEC-DOCUMENT>0001493152-21-004461.txt : 20210222
<SEC-HEADER>0001493152-21-004461.hdr.sgml : 20210222
<ACCEPTANCE-DATETIME>20210222073016
ACCESSION NUMBER:		0001493152-21-004461
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210218
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210222
DATE AS OF CHANGE:		20210222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONVERSION LABS, INC.
		CENTRAL INDEX KEY:			0000948320
		STANDARD INDUSTRIAL CLASSIFICATION:	SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840]
		IRS NUMBER:				760238453
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39785
		FILM NUMBER:		21658247

	BUSINESS ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		(866) 351-5907

	MAIL ADDRESS:	
		STREET 1:		800 THIRD AVENUE, SUITE 2800
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Immudyne, Inc.
		DATE OF NAME CHANGE:	20120514

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IMMUDYNE INC
		DATE OF NAME CHANGE:	19950720
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
8-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pursuant
to Section 13 or 15(d) of the Securities and Exchange Act of 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date
of Report (Date of earliest event reported): February 18, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>LifeMD,
Inc.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of Registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>001-39785</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>76-0238453</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(State
                                         or other jurisdiction</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
        incorporation)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Commission</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
        Number)</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(IRS
                                         Employer</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Identification
        No.)</B></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>800
Third Avenue, Suite 2800</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>New
York, NY 10022</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
of principal executive offices, including zip code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>(866)
351-5907</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Registrant&rsquo;s
telephone number, including area code)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conversion
Labs, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Former
Name or Former Address, if Changed Since Last Report)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under
any of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 28%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 27%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%; border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LFMD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Nasdaq Stock Market LLC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
&sect;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Item 5.03</B></FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
<FONT STYLE="background-color: white">February 18</FONT>, 2021, <FONT STYLE="background-color: white">LifeMD, Inc.</FONT>, formerly
known as <FONT STYLE="background-color: white">Conversion Labs</FONT>, Inc., a Delaware corporation (the &ldquo;Company&rdquo;),
filed a Certificate of Amendment (the &ldquo;Certificate of Amendment&rdquo;) to its Certificate of Incorporation (as amended,
the &ldquo;Certificate of Incorporation&rdquo;) with the Secretary of State of the State of Delaware to effect a change of the
Company&rsquo;s name from &ldquo;<FONT STYLE="background-color: white">Conversion Labs</FONT>, Inc.&rdquo; to &ldquo;LifeMD, Inc.&rdquo;
effective as of February 19, 2021 (the &ldquo;Name Change&rdquo;). <FONT STYLE="background-color: white">The </FONT>Name Change
<FONT STYLE="background-color: white">was approved by the Company&rsquo;s Board of Directors on February 16, 2021. Under Section
242 of the Delaware General Corporation Law, the </FONT>Name Change <FONT STYLE="background-color: white">does not require stockholder
approval. The </FONT>Name Change <FONT STYLE="background-color: white">does not affect the rights of the Company&rsquo;s security
holders. There were no other changes to the Company&rsquo;s Certificate of Incorporation in connection with the </FONT>Name Change<FONT STYLE="background-color: white">.
A copy of the Certificate of Amendment is filed as Exhibit 3.1 hereto and incorporated by reference herein.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7.01. Regulation FD Disclosure.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
February 22, 2021, the trading symbol for the Company&rsquo;s common stock, par value $0.01 per share on The Nasdaq Stock Market
LLC will be &ldquo;LFMD&rdquo; (the &ldquo;Symbol Change&rdquo;). The Company&rsquo;s new CUSIP number is 53216B104.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2021, the Company issued a press release announcing the Name Change and the Symbol Change. A copy of the press release
is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
9.01. Exhibits.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(d)
Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="ex3-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment</FONT></A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press Release</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LifeMD,
    Inc.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    February 22, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Justin Schreiber</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin
                                         Schreiber</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Executive Officer</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF AMENDMENT TO </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATE
OF INCORPORATION </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
CONVERSION LABS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the provisions of Section 242 of the General Corporation Law of the State of Delaware, as amended (the &ldquo;<U>DGCL</U>&rdquo;),
Conversion Labs, Inc., a corporation organized and existing under and by virtue of the DGCL (the &ldquo;<U>Corporation</U>&rdquo;),
does hereby certify:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
that by unanimous written consent of the Board of Directors of Conversion Labs, Inc., dated February 16, 2021 and executed in
accordance with Section 141(f) of the DGCL, resolutions were duly adopted setting forth a proposed amendment of the Amended Certificate
of Incorporation of the Corporation to change the Corporation&rsquo;s name from &ldquo;Conversion Labs, Inc.&rdquo; to &ldquo;LifeMD,
Inc.&rdquo;, declaring said amendment to be advisable and in the best interest of the Corporation and its stockholders. The resolution
setting forth the proposed amendment is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
That the Amended Certificate of Incorporation of this Corporation be amended by amending Article 1 so that, as amended, said Article
shall be and read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article
1: the name of the Corporation has been changed to: LifeMD, Inc.&#9;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
that said amendment was duly adopted in accordance with the provisions of Section 242 of the DGCL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
that said amendment shall be effective at 4:01 p.m. (Eastern Time) on February 19, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its officer thereunto duly authorized
this 17th day of February 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 4.5pt; text-align: justify; text-indent: 35.35pt; color: #050505"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONVERSION
    LABS, INC.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Justin Schreiber </I></FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Justin
    Schreiber</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 259.4pt; text-indent: 0.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 7.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #535D60"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 67px; width: 200px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; color: #535D60">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conversion
Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEW
YORK, NY, February 22, 2021 &mdash; <U>Conversion Labs, Inc</U>.</B> (NASDAQ: CVLB) (NASDAQ: LFMD), a leading direct-to-patient
telehealth company, will begin trading at the opening of the market today under its new name, LifeMD, Inc., and Nasdaq ticker
symbol, LFMD. The stock&rsquo;s new CUSIP number will be 53216B 104.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
new name reflects our evolution from a healthcare-focused performance marketing business into a leading provider of personalized,
direct to patient telehealth services,&rdquo; stated Justin Schreiber, LifeMD&rsquo;s co-founder and CEO. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
vision is to radically change healthcare by making access to the best physicians and prescription medications easily accessible,
convenient, and affordable. From discreetly treating men&rsquo;s sexual health to providing long term concierge care, we believe
we can dramatically improve the health and happiness of countless Americans.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new name also heralds the upcoming official launch of LifeMD&trade;, the company&rsquo;s new subscription-based primary care and
concierge service designed to positively transform the healthcare experience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 205pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stefan
Galluppi, company co-founder and chief technology officer, commented: &ldquo;As one of the earliest and now largest players in
the telemedicine space, we have been able to capitalize on the major paradigm shift in healthcare. Much of this has been made
possible by advancements in digital health technology, and now the widespread increasing demand for virtual healthcare services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;As
now LifeMD, we will focus on scaling the size and reach of our digital health ecosystem, including expanding our suite of telehealth
brands for men and women that will be offered through our new digital health concierge service.&rdquo; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company recently introduced a new subscription-based service for its popular Shapiro MD hair products for men and women like it
did for its <U>Rex MD</U> product line early last year. The company is also set to launch <U>Nava MD</U>, a new teledermatology
brand for women delivered by a patented and clinically proven OTC technology platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD
earlier <U>announced</U> its preliminary results for 2020, reporting revenue up 205% to $38.0 million. Record sales in the month
of December ended the year at an annualized revenue run-rate of more than $60 million. Annual recurring revenue (ARR) generated
by subscriptions is expected to total $26.0 million at yearend 2020, up 525% year-over-year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>About
LifeMD</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD,
Inc. (formerly Conversion Labs) is a leading telehealth company offering a full portfolio of direct-to-patient products and services.
The company combines virtual medical treatment with prescription medications and unique over-the-counter products. LifeMD&rsquo;s
network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. To learn
more, go to <U>LifeMD.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Annual Recurring Revenue</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
company calculates its annual recurring revenue (ARR) by multiplying by 12 the monthly sum of revenue attributed exclusively to
automatic subscription sales from customers that are engaged in the company&rsquo;s rebill structure as it applies to its main
brands: Shapiro MD, Rex MD and PDFSimpli. In the company&rsquo;s calculation of ARR, it does not consider single sales from customers
that repurchase its products through the company&rsquo;s standard checkout pages, Amazon Marketplace or involving the assistance
of a customer service representatives. It also does not include revenue from the initial purchase of a new subscriber.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Important
Cautions Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E
of the Securities Exchange Act of 1934, as amended, regarding, among other things our plans, strategies and prospects &mdash;
both business and financial. Although we believe that our plans, intentions and expectations reflected in or suggested by these
forward-looking statements are reasonable, we cannot assure you that we will achieve or realize these plans, intentions or expectations.
Forward-looking statements are inherently subject to risks, uncertainties and assumptions. Many of the forward-looking statements
contained in this news release may be identified by the use of forward-looking words such as &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;should,&rdquo; &ldquo;planned,&rdquo; &ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;intend,&rdquo;
&ldquo;estimated,&rdquo; and &ldquo;potential,&rdquo; among others. Important factors that could cause actual results to differ
materially from the forward-looking statements we make in this news release include market conditions and those set forth in reports
or documents that we file from time to time with the United States Securities and Exchange Commission. All forward-looking statements
attributable to LifeMD, Inc. or a person acting on its behalf are expressly qualified in their entirety by this cautionary language.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LifeMD&trade;,
Veritas MD&trade;, Shapiro MD&trade;, Rex MD&trade; and Nava MD&trade; are trademarks of LifeMD. All other trademarks are the
property of their respective owners.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">LifeMD,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email
Contact</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media
and Investor Relations Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ron
Both or Grant Stude</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CMA
Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel
(949) 432-7566</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email
Contact</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #2F5496; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; color: #2F5496"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #2F5496; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "5 ;\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MBR^(7AZ\4;KIK=S_  RH1^HS6<J4H]#2%>$NIU-%8Q\6: %W'5;;'^]67?\
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; HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
